[Post-exposure drug prevention of HIV infection].
Rave
K
K
Zentrum für Innere Medizin, Universitirsklinikum Essen.
Jablonowski
H
H
Ross
B
B
Philipp
T
T
D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D016602:Needlestick Injuries; D009784:Occupational Diseases / Q000209:etiology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015215:Zidovudine / Q000008:administration & dosage / Q000009:adverse effects
D019380:Anti-HIV Agents; D015215:Zidovudine